AAA Jennifer Hill

Phagenesis expands series B round

Phagenesis, a UK-based medical device company focused on the treatment of dysphagia, has expanded its series B round to $17m. It originally announced a €7m ($9.1m) first close led by Inventages, a life sciences firm backed by Switzerland-based food and nutrition corporation Nestlé, in autumn 2011. Founded in 2007 after it spun off from research… Continue reading Phagenesis expands series B round